1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69: 7-34.
2 DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A et al. Breast cancer statistics, 2019. CA Cancer J Clin 2019.
3 Song Z, Zhang X, Lin Y, Wei Y, Liang S, Dong C. LINC01133 inhibits breast cancer invasion and metastasis by negatively regulating SOX4 expression through EZH2. J Cell Mol Med 2019; 23: 7554-7565.
4 van Staalduinen J, Baker D, Ten Dijke P, van Dam H. Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer? Oncogene 2018; 37: 6195-6211.
5 Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H et al. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 2015; 527: 525-530.
6 Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong ST et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 2015; 527: 472-476.
7 Yao N, Fu Y, Chen L, Liu Z, He J, Zhu Y et al. Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis. Oncogene 2019.
8 Tan X, Li Z, Ren S, Rezaei K, Pan Q, Goldstein AT et al. Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer. Breast Cancer Res 2019; 21: 89.
9 Zhou T, Yu L, Huang J, Zhao X, Li Y, Hu Y et al. GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple-negative breast cancer via upregulation of Smad7. Aging (Albany NY) 2019; 11: 3298-3314.
10 Jia X, Shi L, Wang X, Luo L, Ling L, Yin J et al. KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation. Cell Death Dis 2019; 10: 373.
11 Dunin-Horkawicz S, Czerwoniec A, Gajda MJ, Feder M, Grosjean H, Bujnicki JM. MODOMICS: a database of RNA modification pathways. Nucleic Acids Res 2006; 34: D145-149.
12 Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci U S A 1974; 71: 3971-3975.
13 Chen XY, Zhang J, Zhu JS. The role of m(6)A RNA methylation in human cancer. Mol Cancer 2019; 18: 103.
14 Cai X, Wang X, Cao C, Gao Y, Zhang S, Yang Z et al. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g. Cancer Lett 2018; 415: 11-19.
15 Yu HL, Ma XD, Tong JF, Li JQ, Guan XJ, Yang JH. WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells. Onco Targets Ther 2019; 12: 6191-6201.
16 Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer 2020; 19: 106.
17 Lan T, Li H, Zhang D, Xu L, Liu H, Hao X et al. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Mol Cancer 2019; 18: 186.
18 Miao R, Dai CC, Mei L, Xu J, Sun SW, Xing YL et al. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer. J Cell Physiol 2020; 235: 7420-7432.
19 Wang M, Yang Y, Yang J, Yang J, Han S. circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m(6)A-YTHDF3-Zeb1. Life Sci 2020; 257: 118082.
20 Li N, Zhan X. Identification of pathology-specific regulators of m(6)A RNA modification to optimize lung cancer management in the context of predictive, preventive, and personalized medicine. Epma j 2020; 11: 485-504.
21 Qian JY, Gao J, Sun X, Cao MD, Shi L, Xia TS et al. KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner. Oncogene 2019; 38: 6123-6141.
22 Shi L, Xia TS, Wei XL, Zhou W, Xue J, Cheng L et al. Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer. Oncotarget 2015; 6: 12264-12278.
23 Zhou XJ, Wu J, Shi L, Li XX, Zhu L, Sun X et al. PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer. J Exp Clin Cancer Res 2017; 36: 149.
24 Zhu L, Xi PW, Li XX, Sun X, Zhou WB, Xia TS et al. The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression. J Exp Clin Cancer Res 2019; 38: 105.
25 Sun X, Hu Y, Wu J, Shi L, Zhu L, Xi PW et al. RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer. J Exp Clin Cancer Res 2018; 37: 298.
26 Li XX, Shi L, Zhou XJ, Wu J, Xia TS, Zhou WB et al. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer. J Exp Clin Cancer Res 2017; 36: 49.
27 Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC et al. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Mol Cancer 2019; 18: 110.
28 Kaufhold S, Bonavida B. Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. J Exp Clin Cancer Res 2014; 33: 62.
29 Li Z, Zhang P, Yan A, Guo Z, Ban Y, Li J et al. ASXL1 interacts with the cohesin complex to maintain chromatid separation and gene expression for normal hematopoiesis. Sci Adv 2017; 3: e1601602.
30 Cheng X, Li M, Rao X, Zhang W, Li X, Wang L et al. KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA. Onco Targets Ther 2019; 12: 3421-3428.
31 Han Q, Yang J, Yang H, Li C, Li J, Cao Y. KIAA1429 promotes osteosarcoma progression by promoting stem cell properties and is regulated by miR-143-3p. Cell Cycle 2020; 19: 1172-1185.
32 Chen Y, Peng C, Chen J, Chen D, Yang B, He B et al. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Mol Cancer 2019; 18: 127.
33 Yang X, Zhang S, He C, Xue P, Zhang L, He Z et al. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer 2020; 19: 46.
34 Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology 2018; 67: 2254-2270.
35 Ma JZ, Yang F, Zhou CC, Liu F, Yuan JH, Wang F et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing. Hepatology 2017; 65: 529-543.
36 Musio A. The multiple facets of the SMC1A gene. Gene 2020; 743: 144612.
37 Ramanathan M, Porter DF, Khavari PA. Methods to study RNA-protein interactions. Nat Methods 2019; 16: 225-234.